Skip to main content
. Author manuscript; available in PMC: 2016 Oct 21.
Published in final edited form as: Fam Cancer. 2013 Dec;12(4):597–600. doi: 10.1007/s10689-013-9618-y

Table 2.

Patient and tumor characteristics of HOXB13 mutation (rs138213197) heterozygous carriers in 920 non-Ashkenazi sporadic prostate cancer patients treated at Memorial Sloan Kettering-Cancer Center

Age at
diagnosis
PSA at
diagnosis
Gleason
score
TNM stage Metastasis Death
from
Prostate
Cancer
70 < 10 4+5 T3cN0MX Yes Unknown
66 < 10 3+3 T1c Unknown Unknown
78 Unknown 5+5 T3aN1M1b Yes Yes
49 >10 3+4 T3aN1M0 No No